Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.	Advanced Solid Tumor	Recruiting	Phase 1	2025-11-25		NCT05547321

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alcura Health España SA	1
Anapharm Bioanalytics	1
Biotrial	2
Centro de Investigación del Cáncer Universidad de Salamanca	1
Certara	1
Clinigen, Inc.	3
CTI Laboratory Services Spain	1
Evidenze CRO	5
HistoOne	1
Oncomatryx Biopharma S.L.	2
Opthimapharm	1
TFS Health Science	1

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beth Israel Deaconess Medical Center	Boston	United States	462
Clínica Universitaria de Navarra	Pamplona	Spain	1
Hospital 12 Octubre	Madrid	Spain	1
Hospital Clínico Universitario de Santiago	Santiago de Compostela	Spain	2
Hospital MD Anderson	Madrid	Spain	1
Hospital Universitari Vall d'Hebron	Barcelona	Spain	9
Hospital Universitario de Donostia	San Sebastián	Spain	2
ICO l'Hospitalet	L'Hospitalet de Llobregat	Spain	2
Onkologikoa	San Sebastián	Spain	1